We are live on ! Find out more
VTRS icon

Viatris

1,010 hedge funds and large institutions have $11.5B invested in Viatris in 2024 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 313 increasing their positions, 411 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more call options, than puts

Call options by funds: $56M | Put options by funds: $37.2M

11% more capital invested

Capital invested by funds: $10.4B → $11.5B (+$1.12B)

1.24% more ownership

Funds ownership: 79.97%81.21% (+1.2%)

9% more first-time investments, than exits

New positions opened: 102 | Existing positions closed: 94

1% less funds holding

Funds holding: 1,0161,010 (-6)

8% less funds holding in top 10

Funds holding in top 10: 1211 (-1)

24% less repeat investments, than reductions

Existing positions increased: 313 | Existing positions reduced: 411

Holders
1,010
Holders Change
-6
Holders Change %
-0.59%
% of All Funds
14.52%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.16%
New
102
Increased
313
Reduced
411
Closed
94
Calls
$56M
Puts
$37.2M
Net Calls
+$18.9M
Net Calls Change
+$11.5M

VTRS Hedge Fund Activity: Q1 2024 in Review

1,010 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q1 2024, worth a combined $11.5B — up 11% from $10.4B a quarter earlier.

Buyers outnumbered sellers: 102 funds opened new VTRS positions and 94 closed out — a net gain of 8 holders — while 313 added to existing stakes and 411 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $101M. The largest seller was Davis Selected Advisers, cutting an estimated $62.6M.

  • 1,010 institutional investors held Viatris (VTRS) as of Q1 2024, down from 1,016 in Q4 2023.
  • Funds reported $11.5B of Viatris stock for Q1 2024, up 11% quarter-over-quarter.
  • 102 funds opened new Viatris positions in Q1 2024 and 94 closed out, a net change of +8 holders.
  • The largest Viatris buyer in Q1 2024 was T. Rowe Price Associates, an estimated $101M added.
  • The largest Viatris seller in Q1 2024 was Davis Selected Advisers, an estimated $62.6M sold.

Based on aggregated 13F filings for Q1 2024.